A P2L2 postmenopausal lady came with a history of mass PV with difficulty to walk and pain in the left hip. She also had a scan report showing a left complex adnexal mass suggesting ovarian malignancy. GPE showed a vague mass in the LIF which on CT scan was diagnosed as a retroperitoneal neoplasm measuring 100 × 70 × 80 mm. Core needle biopsy of the mass came as poorly differentiated metastatic carcinoma. No primary found. Palliative chemotherapy for 6 cycles with Paclitaxel and Cisplatin was given and the mass completely regressed in size.
INTRODUCTION
Retroperitoneal tumors are rare and present insidiously. It is not unusual for retroperitoneal sarcoma to present to a gynecologist as a first point of specialist reference usually with an ultrasound diagnosis suggesting ovarian malignancy. We need to be aware of the possibility of retroperitoneal sarcomas in the assessment of a pelvic mass. 1, 2 The importance of computed tomography in the differential diagnosis and appropriate management of retroperitoneal tumor is emphasized here. 3 Laparotomy by surgeons inexperienced with retroperitoneal tumors should be avoided as it prejudices the chances of a long, disease free interval and possibly adversely affects the chances of cure. 4 This paper reviews the above problems and makes a number of suggestions.
CASE REPORT
Mrs V aged 45 years; a postmenopausal lady from low socioeconomic status, P2L2, came to the Casualty of MS Ramaiah Medical Teaching Hospital, Bengaluru on 30-12-2007 with history of pain in the left hip since 6 months, low back pain since 2 months and inability to walk since 15 days. She also gave history of mass per vagina since 2 years. With the above complaints, she was admitted to the orthopedics department. GPE was normal. Orthopedic examination showed left sided fixed flexion deformity of 30° at the hip and 20°f lexion of the left knee. Painful but full range of movements was present. Routine investigations were normal. X-ray hip was normal. Patient had a pelvic scan report dated 17-11-2007 showing a left adnexal complex mass of 6.1 × 4.2 cm with left-sided hydronephrosis. Uterus and right ovary normal. Patient was shifted to OBG department with skin traction for 1 week.
Evaluation at OBG department showed a vague mass with ill defined margins in the left iliac fossa with evidence of guarding. Pelvic examination showed a III degree UV prolapse with grade II cystocele and rectocele. Cervix hypertrophied and cervical lips everted. PV examination revealed the uterus to be retroverted and normal size, mobile, with fullness/vague mass in the left fornix. Right fornix was free. Repeat pelvic scan done confirmed the presence of left adnexal complex cyst measuring 80 × 68 × 75 mm with thick wall internal septations and mural nodule suggesting ovarian malignancy. Uterus and right ovary was normal. Left-sided hydronephrosis present. Minimal free fluid in the pouch of Douglas present.
Further evaluation showed CA 125 and CEA to be within normal limits. Pap smear showed no evidence of malignancy. ECC done did not yield any material. Colposcopy and guided biopsy confirmed to chronic nonspecific cervicitis. Upper and lower GI endoscopy was normal. Orthopedic review, opined as arthritis of the left hip with flexion deformity. Surgical opinion conferred to an ovarian mass with no other pathology detected.
EUA done revealed a hard fixed immobile mass on the left side of the abdomen, as psoas muscle spasm was eliminated under GA, the flexion deformity of the left hip and knee joints disappeared and the abdomen relaxed. Surgical oncologist opined it as a mass arising from the bone/organized tubercular mass. Further evaluation needed. CT scan done revealed upper abdomen to be normal. No evidence of lymphadenopathy or ascitis. A cystic retroperitoneal mass in the left pelvic region measuring 100 × 70 × 80 mm encasing the external iliac vessels splayed medially (Fig. 1) . Left ureter infiltrated and occluded with significant hydroureteronephrosis (Figs 2 to 4) . Mass adherent to iliacus and psoas muscle, uterus normal. Ovaries not identified. So, a diagnosis of a retroperitoneal mass as described was made along with possibilities of left ovarian neoplasm with adjacent retroperitoneal infiltration/? Primary retroperitoneal neoplasm made. Core needle biopsy of the mass done under LA. The report came as poorly differentiated carcinoma-metastatic, immunohistochemistry advised.
Search for primary made. ENT examination normal. FNAC thyroid showed no evidence of malignancy. Thyroid and breast scans normal. Endometrial biopsy showed no malignancy. No primary found. So, a diagnosis of occult primary with retroperitoneal secondaries made. Consultations done with radiotherapist and medical oncologist. 
DISCUSSION
The lessons learnt from this case are that any vague mass felt per abdomen-think beyond an ovarian mass. Evidence of obstruction like hydroureteronephrosis with a predominant solid tumor showing clinical signs of vascular or rectal displacements, we should consider other less common d/d of pelvic mass. 5 Fixed flexion deformity of the hip (Psoas spasm) with mass per abdomen may not be ovarian cyst alone. 6 Misinterpretation of the clinical signs with overemphasis on ultrasound can lead to a wrong diagnosis and may result in unnecessary laparotomy. 1 Poorly differentiated types have few lipoma-like tissues with increasing internal bleeding or necrosis making a precise diagnosis on imaging alone difficult. Because, these tumors response to treatment and prognosis varies depending on the level of differentiation, biopsy as a JSAFOG final diagnosis is important. 7 Patients with advanced poorly differentiated carcinoma should be considered for cisplatinbased combination chemotherapy, especially if tumor occurs predominantly in the mediastinum, retroperitoneum or lymph nodes. 8 Patient came walking to the OBG department for review and was comfortable. No mass felt per abdomen. Ring pessary was inserted as a conservative treatment for uterovaginal prolapse. Repeat abdominopelvic scan showed complete regression of the mass and the patient is on regular medical oncology and OBG follow-up.
